Collectively, COL1A1 down-regulation may inhibit exosome secretion possibly via inhibiting COL I and upregulating CAV-1, thereby inhibiting tumor-associated fibroblast activation and matrix remodeling in the tumor microenvironment. The gene discussed is COL1A1; the disease is neoplasm.